Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Clonal origin and spread of metastatic prostate cancer
Jamie L. Van Etten,
Scott M. Dehm
Masonic Cancer Center
Laboratory Medicine and Pathology
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clonal origin and spread of metastatic prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Androgen Deprivation Therapy
33%
Castration-resistant Prostate Cancer
33%
Cell Tumor
33%
Chemical Castration
33%
Circulating Tumor Cells
33%
Circulating Tumor DNA (ctDNA)
33%
Clonal Evolution
33%
Clonal Origin
100%
Clonal Spread
100%
Disease Progression
33%
Disease Regression
33%
Disease Stage
33%
Genetic Evolution
66%
Genome Composition
33%
Health-to-disease Transition
33%
Large-scale Sequencing
33%
Metastasis
33%
Metastatic Disease
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Metastatic Site
33%
Prostate Cancer
66%
Prostate Cancer Genome
33%
Prostate Cancer Risk
33%
Resistance to Therapy
33%
Response to Therapy
33%
Sequencing Studies
33%
Spatial Landscape
33%
Surgical Castration
33%
Medicine and Dentistry
Androgen Deprivation Therapy
20%
Cancer Mortality
20%
Castration Resistant Prostate Cancer
20%
Circulating Tumor Cell
20%
Circulating Tumor DNA
20%
Disease
20%
Disease Exacerbation
20%
Metastatic Carcinoma
80%
Prostate Cancer
100%
Spontaneous Remission
20%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
20%
Cancer Mortality
20%
Castration Resistant Prostate Cancer
20%
Circulating Tumor DNA
20%
Disease
20%
Disease Exacerbation
20%
Metastasis
60%
Neoplasm
20%
Prostate Cancer
100%
Remission
20%
Biochemistry, Genetics and Molecular Biology
Cancer Mortality
50%
Circulating Tumor DNA
50%
Clonal Evolution
50%
Genetics
100%
Genomics
50%
Material Science
Phase Composition
50%
Tumor
100%
Agricultural and Biological Sciences
Androgen
100%